Cercare Medical A/S — Credit Rating and Financial Key Figures
CVR number: 35483489
Inge Lehmanns Gade 10, 8000 Aarhus C
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 | 12 |
Net sales | |||||
Gross profit | -2 851.98 | -4 390.49 | -18 800.48 | -24 371.32 | -31 641.82 |
Employee benefit expenses | -11 220.45 | -14 677.80 | -14 937.71 | -18 375.84 | -23 015.23 |
Other operating expenses | -1 966.77 | - 123.54 | |||
Total depreciation | - 559.58 | - 671.14 | - 666.19 | - 632.68 | - 222.10 |
EBIT | -16 598.77 | -19 739.44 | -34 527.92 | -43 379.85 | -54 879.16 |
Other financial income | 13.70 | 28.71 | 45.24 | 39.32 | 242.75 |
Other financial expenses | - 166.59 | - 246.81 | - 459.94 | -1 652.82 | -1 087.56 |
Net income from associates (fin.) | - 174.54 | - 396.39 | |||
Pre-tax profit | -16 751.67 | -19 957.54 | -34 942.62 | -45 167.88 | -56 120.35 |
Income taxes | 2 097.39 | 1 663.94 | 3 015.57 | 2 743.22 | 2 834.99 |
Net earnings | -14 654.28 | -18 293.60 | -31 927.06 | -42 424.66 | -53 285.36 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Intangible rights | 1 254.89 | 1 033.12 | 868.36 | 747.47 | 684.66 |
Intangible assets total | 1 254.89 | 1 033.12 | 868.36 | 747.47 | 684.66 |
Buildings | 69.60 | 52.20 | 34.80 | 17.40 | |
Machinery and equipment | 470.66 | 501.67 | 308.94 | 13.95 | 0.01 |
Tangible assets total | 470.66 | 571.27 | 361.14 | 48.75 | 17.40 |
Investments total | 146.44 | 224.52 | 278.14 | 269.22 | 273.98 |
Long term receivables total | |||||
Inventories total | |||||
Current trade debtors | 182.52 | 472.58 | 162.48 | 2 116.23 | 622.36 |
Current amounts owed by group member comp. | 24.14 | 97.42 | |||
Prepayments and accrued income | 38.49 | 45.52 | 306.86 | 59.82 | 345.08 |
Current other receivables | 323.69 | 23 073.09 | 571.62 | 693.28 | 768.52 |
Current deferred tax assets | 2 096.57 | 1 663.94 | 3 015.57 | 2 743.22 | 2 834.99 |
Short term receivables total | 2 641.27 | 25 255.14 | 4 056.52 | 5 636.69 | 4 668.37 |
Cash and bank deposits | 38 760.22 | 3 250.56 | 3 794.97 | 19 839.27 | 30 955.97 |
Cash and cash equivalents | 38 760.22 | 3 250.56 | 3 794.97 | 19 839.27 | 30 955.97 |
Balance sheet total (assets) | 43 273.48 | 30 334.60 | 9 359.14 | 26 541.40 | 36 600.38 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Share capital | 475.45 | 485.37 | 485.37 | 761.61 | 957.83 |
Retained earnings | 54 986.60 | 45 910.02 | 27 616.42 | 61 518.53 | 83 156.31 |
Profit of the financial year | -14 654.28 | -18 293.60 | -31 927.06 | -42 424.66 | -53 285.36 |
Shareholders equity total | 40 807.78 | 28 101.79 | -3 825.26 | 19 855.48 | 30 828.77 |
Non-current other liabilities | 767.19 | ||||
Non-current liabilities total | 767.19 | ||||
Current loans from credit institutions | 122.61 | ||||
Advances received | 26.02 | 18.75 | |||
Current trade creditors | 243.19 | 1 242.78 | 1 396.29 | 2 534.30 | 1 329.74 |
Current owed to participating | 10 267.24 | ||||
Other non-interest bearing current liabilities | 1 332.71 | 990.03 | 829.12 | 1 277.31 | 2 526.18 |
Accruals and deferred income | 665.73 | 2 855.57 | 1 915.69 | ||
Current liabilities total | 1 698.51 | 2 232.81 | 13 184.40 | 6 685.92 | 5 771.61 |
Balance sheet total (liabilities) | 43 273.48 | 30 334.60 | 9 359.14 | 26 541.40 | 36 600.38 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.